CAT No: CP26186
CAS No:109523-13-9
Synonyms/Alias:109523-13-9;(2S,3aS,7aS)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylicacid;Boc-(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylicacid;AC1MBSJV;BOC-OIC-OH;SCHEMBL1336739;CTK8B6934;MolPort-006-705-842;POJYGQHOQQDGQZ-DCAQKATOSA-N;ZINC4899627;ANW-54903;CB-570;AKOS015836489;AKOS015893209;RTR-002060;AJ-52574;AK-90260;SC-68386;KB-206594;Boc-L-Octahydro-1H-indole-2-carboxylicacid;FT-0679858;ST24034079;Z-2431;I04-3751;(2S,3aS,7aS)-N-BOC-octahydroindole-2-carboxylicacid
Boc-L-octahydroindole-2-carboxylic acid is a Boc-protected, L-configured amino acid building block featuring a rigid octahydroindole ring system at the side chain, which makes it a useful chiral scaffold for conformationally constrained peptide and peptidomimetic design. The presence of the Boc group supports protected-amino-acid handling in peptide assembly workflows, while the saturated bicyclic framework provides a distinct steric and three-dimensional shape compared with standard aliphatic or aromatic side chains. As a research-grade amino acid intermediate, it is commonly selected when developers need a non-standard residue for stereochemically defined sequence construction and downstream SAR studies.
1. Constrained Peptide Building
Boc-L-octahydroindole-2-carboxylic acid is used by peptide chemists to introduce a rigid octahydroindole-derived residue into custom peptide sequences where conformational restriction is a design goal. Solid-phase and segment-based peptide synthesis groups rely on this Boc-protected amino acid to prepare sequence-defined intermediates and to evaluate how the bicyclic side-chain topology influences folding, turn propensity, and overall peptide shape. Because the scaffold is non-proteinogenic, it is frequently incorporated into sequence libraries and analog series aimed at structure-activity relationship (SAR) exploration rather than native protein mimicry.
2. Peptidomimetic SAR Intermediates
Boc-L-octahydroindole-2-carboxylic acid supports medicinal chemistry programs that build peptidomimetic backbones and constrained analogs for lead optimization. The octahydroindole ring provides a compact, stereochemically defined substituent that can be used to probe spatial requirements around a pharmacophore while maintaining a peptide-like connectivity pattern. Pharmaceutical intermediate developers often stock this type of protected amino acid building block for the rapid generation of protected coupling fragments and for assembling analogs that require consistent chiral geometry across a series of compounds.
3. Chiral Scaffold Derivative Synthesis
Boc-L-octahydroindole-2-carboxylic acid is applied in the synthesis of chiral, bicyclic amino acid derivatives used as reference building blocks in synthetic chemistry and chemical biology tool development. Researchers value the rigid octahydroindole framework because it can translate into reproducible stereochemical outcomes when constructing downstream amide-linked structures, including modified peptide segments and non-natural residue-containing intermediates. In practical workflows, the Boc protection enables controlled handling during stepwise derivatization, allowing the scaffold to be carried through multi-step synthesis before final coupling or deprotection steps in the broader route.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.